The inflammatory response in myocardial injury, repair, and remodelling.
TLDR
Biomarker-based approaches are needed to identify patients with distinct pathophysiologic responses and to rationally implement inflammation-modulating strategies in patients with myocardial infarction.Abstract:
Myocardial infarction triggers an intense inflammatory response that is essential for cardiac repair, but which is also implicated in the pathogenesis of postinfarction remodelling and heart failure. Signals in the infarcted myocardium activate toll-like receptor signalling, while complement activation and generation of reactive oxygen species induce cytokine and chemokine upregulation. Leukocytes recruited to the infarcted area, remove dead cells and matrix debris by phagocytosis, while preparing the area for scar formation. Timely repression of the inflammatory response is critical for effective healing, and is followed by activation of myofibroblasts that secrete matrix proteins in the infarcted area. Members of the transforming growth factor β family are critically involved in suppression of inflammation and activation of a profibrotic programme. Translation of these concepts to the clinic requires an understanding of the pathophysiological complexity and heterogeneity of postinfarction remodelling in patients with myocardial infarction. Individuals with an overactive and prolonged postinfarction inflammatory response might exhibit left ventricular dilatation and systolic dysfunction and might benefit from targeted anti-IL-1 or anti-chemokine therapies, whereas patients with an exaggerated fibrogenic reaction can develop heart failure with preserved ejection fraction and might require inhibition of the Smad3 (mothers against decapentaplegic homolog 3) cascade. Biomarker-based approaches are needed to identify patients with distinct pathophysiologic responses and to rationally implement inflammation-modulating strategies.read more
Citations
More filters
Cellular and molecular players in vascular and left ventricular remodeling
TL;DR: This thesis addresses 3 important areas of ischemic heart disease: Developing novel methods for patient diagnosis and stratification, understanding the monocytic response, and identifying novel therapeutic targets based on genetic heterogeneity of patients.
Journal ArticleDOI
Acute-Phase Inflammatory Reaction Predicts CMR Myocardial Scar Pattern and 2-Year Mortality in STEMI Patients Undergoing Primary PCI
András Mester,Nora Rat,Theodora Benedek,Diana Opincariu,Roxana Hodas,Monica Chițu,Imre Benedek +6 more
TL;DR: The CMR pattern of myocardial scarring after 1 month, as expressed by the magnitude of IS and transmurality, is a significant predictor for 2-year mortality after revascularized STEMI.
Journal ArticleDOI
NLRP3 inflammasome as a novel therapeutic target for heart failure
TL;DR: In this paper , the authors systematically summarize evidence regarding the relationship among NLRP3 inflammasome, energy metabolism, intestinal microflora metabolites, and inflammation, as well as highlight advantages of NLRP-3 in treating heart failure.
Journal ArticleDOI
Berberine plays a cardioprotective role by inhibiting macrophage Wnt5a/β‐catenin pathway in the myocardium of mice after myocardial infarction
Chunxia Tian,Mingyue Ji,Xinxin Shuai,Feng Jiang,Yalan Dong,Yang Gui,Zili Zhang,Ren-Jie Qin,Zhenyu Kang,Lan-yi Lin,Alexey Sarapultsev,Bin Wu,Shanshan Luo,Desheng Hu +13 more
TL;DR: BBR effectively improved cardiac function of mice after MI, and the potential protective mechanism was associated with the regulation of inflammatory responses and the inhibition of macrophage Wnt5a/β-catenin pathway in the infarcted heart tissues.
Journal ArticleDOI
Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
Xiaoying Yin,Xinxin Yin,Xin Pan,Jingyu Zhang,Xinhui Fan,Jiaxin Li,Xiaoxuan Zhai,Lijun Jiang,Panpan Hao,Jiali Wang,Yuguo Chen +10 more
TL;DR: In this paper , the authors aim to elaborate pathophysiology, examination and intervention of cardiac fibrosis after myocardial infarction (MI) using pathophysiological models.
References
More filters
Journal ArticleDOI
Getting to the site of inflammation: the leukocyte adhesion cascade updated
TL;DR: This Review focuses on new aspects of one of the central paradigms of inflammation and immunity — the leukocyte adhesion cascade.
Journal ArticleDOI
DAMPs, PAMPs and alarmins: all we need to know about danger
TL;DR: The term “alarmin” is proposed to categorize such endogenous molecules that signal tissue and cell damage, and can be considered subgroups of a larger set, the damage‐associated molecular patterns (DAMPs).
Journal ArticleDOI
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
Harvey D. White,R M Norris,Michael A. Brown,Peter W.T. Brandt,Ralph M.L. Whitlock,Chris J. Wild +5 more
TL;DR: Volume, ejection fractions, and severity of coronary arterial occlusions and stenoses in 605 male patients under 60 years of age at 1 to 2 months after a first or recurrent myocardial infarction showed that end-systolic volume had greater predictive value for survival than end-diastolic volume or ejection fraction.
Journal ArticleDOI
Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling
TL;DR: Left ventricular end-diastolic and end-systolic volume and ejection fraction data provide support for the beneficial effects of therapeutic agents such as angiotensin-converting enzyme (ACE) inhibitors and beta-adrenergic blocking agents on the remodeling process.
Related Papers (5)
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker,Brendan M. Everett,Tom Thuren,Jean G. MacFadyen,William Chang,Christie M. Ballantyne,Francisco H. Fonseca,Jose C. Nicolau,Wolfgang Koenig,Stefan D. Anker,John J.P. Kastelein,Jan H. Cornel,Prem Pais,Daniel Pella,Jacques Genest,Renata Cifkova,Alberto J. Lorenzatti,Tamás Forster,Zhanna Kobalava,Luminita Vida-Simiti,Marcus Flather,Hiroaki Shimokawa,Hisao Ogawa,Mikael Dellborg,Paulo Roberto Ferreira Rossi,Roland P.T. Troquay,Peter Libby,Robert J. Glynn +27 more